Fund+ is a venture capital fund specializing in Life Sciences and Deep Tech industries. They focus on Series B investments, supporting companies like Minoryx Therapeutics. With check sizes between $250k and $5M, Fund+ aims to create sustainable shareholder value and positive societal impact. They prioritize long-term equity investments, particularly in Belgium-based companies.
